Company
AstraZeneca
AstraZeneca has 73 drugs tracked on RxWires: 5 post-market, 5 approved, 28 in Phase 3, 1 in Phase 2/3, 14 in Phase 2, 2 in Phase 1/2, 18 in Phase 1.
- Ticker
- AZN
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| IMP oral tablet | Post-Market | Type 2 Diabetes |
| Sodium zirconium cyclosilicate | Post-Market | Hyperkalemia |
| Aclidinium Bromide | Post-Market | Pulmonary Disease, Chronic Obstructive |
| Tezepelumab | Post-Market | Severe Asthma |
| Ticagrelor monotherapy | Post-Market | Diabetes Mellitus, Type 2 |
| XIGDUO XR | Approved | |
| TAGRISSO | Approved | |
| BYETTA | Approved | |
| SORBITRATE | Approved | |
| BREZTRI AEROSPHERE | Approved | |
| Durvalumab | Phase 3 | Biliary Tract Cancer |
| Lenbelintide | Phase 3 | Obesity or Overweight |
| Selumetinib | Phase 3 | Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV |
| Elecoglipron | Phase 3 | Obesity |
| AZD0780 | Phase 3 | Heterozygous Familial Hypercholesterolaemia |
| Benralizumab | Phase 3 | Eosinophilic Granulomatous Vasculitis |
| AZD6234 | Phase 3 | Obesity |
| Eplontersen | Phase 3 | Transthyretin Amyloid Cardiomyopathy |
| Baxdrostat/dapagliflozin | Phase 3 | Chronic Kidney Disease and Hypertension |
| Torvutatug samrotecan | Phase 3 | Epithelial Ovarian Cancer |
| olaparib | Phase 3 | Endometrial Neoplasms |
| Oleclumab | Phase 3 | Non-Small Cell Lung Cancer |
| Baxdrostat | Phase 3 | Uncontrolled Hypertension |
| Dapagliflozin propanediol (FORXIGA™/FARXIGA™1) | Phase 3 | AMI |
| goserelin acetate | Phase 3 | Prostate Cancer |
| Quetiapine Fumarate Extended- Release | Phase 3 | Schizophrenia |
| Olive oil, 4g | Phase 3 | Hypertriglyceridemia |
| Esomeprazole (Nexium) | Phase 3 | Gastroesophageal Reflux Disease (GERD) |
| AZD7442 | Phase 3 | COVID-19 |
| Trastuzumab Deruxtecan | Phase 3 | Locally Advanced or Metastatic Non-Small Cell Lung Cancer |
| fostamatinib | Phase 3 | Rheumatoid Arthritis |
| Omeprazole | Phase 3 | Non-erosive Reflux Disease |
| Domvanalimab | Phase 3 | Non-Small Cell Lung Cancer |
| Saruparib | Phase 3 | Metastatic Castration-Sensitive Prostate Cancer |
| Anifrolumab | Phase 3 | Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus |
| BDA MDI | Phase 3 | Asthma |
| Datopotamab deruxtecan (Dato-DXd) | Phase 3 | Non-small Cell Lung Cancer (NSCLC) |
| Volrustomig | Phase 3 | Locally Advanced Cervical Cancer |
| FG-4592 | Phase 2/3 | Anemia |
| Exenatide LAR | Phase 2 | Type 2 Diabetes Mellitus |
| AZD2389 | Phase 2 | Liver Fibrosis |
| Rilvegostomig | Phase 2 | Non-Small Cell Lung Cancer |
| AZD5069 | Phase 2 | Bronchiectasis |
| AZD5213 + pregabalin | Phase 2 | Diabetic Neuropathy, Painful; Diabetic Neuropathies |
| AZD9833 | Phase 2 | HER2-negative Breast Cancer |
| ZD1839 | Phase 2 | Non-small Cell Lung Cancer |
| MEDI4736 | Phase 2 | Non-Small Cell Lung Cancer |
| AZD7009, no generic name available | Phase 2 | Atrial Fibrillation |
| ZD6474 | Phase 2 | Lung Cancer |
| AZD1386 | Phase 2 | Pain |
| CIN-107 | Phase 2 | Hypertension |
| AZD5148 | Phase 2 | Clostridioides Difficile Infection |
| AZD7798 | Phase 2 | Moderate to Severe Crohn's Disease |
| AZD0120 | Phase 1/2 | Relapsed/Refractory Multiple Myeloma |
| AZD2936 | Phase 1/2 | Non-Small-Cell Lung Carcinoma |
| AZD0543 | Phase 1 | Human Metapneumovirus Infection |
| AZD1043 | Phase 1 | Obesity |
| AZD1390 | Phase 1 | Advanced Solid Malignancies |
| AZD6765 | Phase 1 | Healthy |
| Candesartan cilexetil | Phase 1 | Hypertension |
| AZD8848 | Phase 1 | Healthy |
| AZD0284 oral solution 2.5 mg/mL | Phase 1 | Plaque Psoriasis Vulgaris |
| Tozorakimab | Phase 1 | Healthy Participants |
| Entinostat | Phase 1 | Fallopian Tube Cancer |
| cyclosporine | Phase 1 | Healthy |
| Form 1 of AZD5718 tablets | Phase 1 | Coronary Artery Disease |
| AZD6714 | Phase 1 | Type 2 Diabetes |
| AZD7268 | Phase 1 | Healthy Volunteer |
| MEDI1341 | Phase 1 | Parkinson's Disease |
| AZD9291 tablet dosing | Phase 1 | Solid Tumours |
| AZD6140 | Phase 1 | Gout |
| Co-administration of Saxagliptin and Metformin IR, Fasted | Phase 1 | Type 2 Diabetes Mellitus |
| Capsule ASA 81mg/esomeprazole 20mg | Phase 1 | Healthy |
Latest
- Volrustomig moved to Phase 3
- Azd0780 moved to Phase 3
- Label updated: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Follow AstraZeneca on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.